Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Biological, AML, Adult, apoptosis, Diseases, Non-Biological, Therapies, Bone Marrow Failure, chemical interactions, Biological Processes, MPN, Technology and Procedures, Polycythemia vera, Cell Lineage, cytogenetics, thrombocythemia, Study Population, Clinically relevant, genomics, Myeloid Malignancies, pharmacology, TKI, molecular testing, molecular interactions, pathways, signal transduction
Type: Oral
Hematology Disease Topics & Pathways:
Biological, AML, Adult, apoptosis, Diseases, Non-Biological, Therapies, Bone Marrow Failure, chemical interactions, Biological Processes, MPN, Technology and Procedures, Polycythemia vera, Cell Lineage, cytogenetics, thrombocythemia, Study Population, Clinically relevant, genomics, Myeloid Malignancies, pharmacology, TKI, molecular testing, molecular interactions, pathways, signal transduction
Sunday, December 6, 2020: 9:30 AM-11:00 AM
Moderators:
Vikas Gupta, MD, FRCP, FRCPath, The Princess Margaret Cancer Centre
and
Gabriela S. Hobbs, MD, Massachusetts General Hospital
Disclosures:
Hobbs: Merck: Research Funding; Incyte: Research Funding; Bayer: Research Funding; Constellation: Honoraria, Research Funding; Jazz: Honoraria; Novartis: Honoraria; Celgene/BMS: Honoraria.
9:30 AM
9:45 AM
10:15 AM
10:30 AM
10:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH